1、1. Li Z, Yu C (共同一作), Zhang H, Chen R, Zhao Y, Zheng Z. Impact of remnant cholesterol on short-term and long-term prognosis in patients with prediabetes or diabetes undergoing coronary artery bypass grafting: a large-scale cohort study. Cardiovasc Diabetol. 2025 Jan 8;24(1):8.(Original Article, IF 8.5, Q1)
2、2. Yu C (第一作者), Liu C, Du J, et al.Smartphone-based application to improve medication adherence in patients after surgical coronary revascularization. Am Heart J 2020;228:17–26.(Original Article, IF 3.7,Q1)
3、3. Yu C (第一作者), Li H, Wang Y, et al. Bi-atrial versus left atrial ablation for patients with rheumatic mitral valve disease and non-paroxysmal atrial fibrillation (ABLATION): Rationale, design and study protocol for a multicenter randomized controlled trial.BMJ Open.doi:10.1136/bmjopen-2022-064861 (Original Article , IF2.4, Q1)
4、4. Yu C (第一作者), Li H, Lei C, Wang Y, Chen S, Zhao Y, Zheng Z. Epicardial left atrial appendage clipping versus direct oral anticoagulant to reduce stroke risk in non-paroxysmal atrial fibrillation (LAA-CLIP): rationale, design and study protocol for a multicentre randomised controlled trial. BMJ Open. 2024 Mar 5;14(3):e083153. (Original Article , IF 2.4, Q1)
5、5. Yu C (第一作者), Li H, Zeng Z, Zheng L, Wu L, Ding L, Yao Y, Zheng Z. Hybrid Biatrial Ablation Versus Catheter Ablation for Patients With Nonparoxysmal Atrial Fibrillation and Enlarged Left Atrium. Innovations (Phila). 2024 Sep-Oct;19(5):511-519. (Original Article , IF 1.6, Q2)
6、6. Yu C (第一作者), Li H, Zhang H, et al. Midterm results of stand-alone thoracoscopic epicardial ablation with box lesion for atrial fibrillation. Interact Cardiovasc Thorac Surg. 2021 Aug 18;33(3):354-361. (Original Article, IF1.9, Q3)
7、7. Li H, Yu C (共同一作), Gao G, et al. Superiority of complete bi-atrial ablation procedure for atrial fibrillation in rheumatic mitral valve disease. J Cardiovasc Electrophysiol.2022 Oct 23. (Original Article, IF 2.9, Q3).